Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
This page is not indexed by search engines while we improve data quality.
Markoff Lewis — Human Necessities
Markoff Lewis holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Markoff Lewis |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2017 |
| Last year | 2017 |
Representative patents
Notable publications linking Markoff Lewis to Human Necessities.
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Recent filings
Latest patents from Markoff Lewis in Human Necessities.
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US-9783787-B2 · Oct 10, 2017 · US
Related pages
Navigate to parent entity pages.